(Q35157693)

6 August 2017

1 reference

title

The quest for a vaccine against Helicobacter pylori: how to move from mouse to man? (English)

1 reference

Helicobacter pylori infectious disease

6 August 2017

0 references

1 reference

3

Rino Rappuoli

1 reference

6 August 2017

Paolo Ruggiero

1

1 reference

6 August 2017

Samuele Peppoloni

series ordinal

2

1 reference

6 August 2017

Giuseppe Del Giudice

series ordinal

4

1 reference

6 August 2017

publication date

1 July 2003

1 reference

6 August 2017

published in

Microbes and Infection

1 reference

6 August 2017

volume

5

1 reference

6 August 2017

issue

8

1 reference

6 August 2017

page(s)

749-756

1 reference

Helicobacter pylori vaccine development and use: a cost-effectiveness analysis using the Institute of Medicine Methodology

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Quantifying the population impact of a prophylactic Helicobacter pylori vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Medicine. The intangible value of vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Helicobacter pylori in Gambian children with chronic diarrhoea and malnutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Helicobacter pylori infection, gastric acid secretion, and infant growth

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Acute Helicobacter pylori infection is followed by an increase in diarrheal disease among Peruvian children

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Helicobacter pylori and epidemic Vibrio cholerae O1 infection in Peru

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Association between Helicobacter pylori infection and increased risk of typhoid fever

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

The design of vaccines against Helicobacter pylori and their development

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Multiparameter selection of Helicobacter pylori antigens identifies two novel antigens with high protective efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Living dangerously: how Helicobacter pylori survives in the human stomach

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Sterilizing immunity against experimental Helicobacter pylori infection is challenge-strain dependent

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Human gastric B cell responses can be induced by intestinal immunisation

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Clearance of Helicobacter pylori Infection and Resolution of Postimmunization Gastritis in a Kinetic Study of Prophylactically Immunized Mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Animal models for gastric Helicobacter immunology and vaccine studies

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Antibody-dependent macrophage-mediated activity against Helicobacter pylori in the absence of complement

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

B cell responses in gastric antrum and duodenum following oral inactivated Helicobacter pylori whole cell (HWC) vaccine and LT(R192G) in H pylori seronegative individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

A conventional beagle dog model for acute and chronic infection with Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

Helicobacter pylori virulence and genetic geography

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2803%2900125-4

7 January 2021

10.1016/S1286-4579(03)00125-4

Identifiers

DOI

1 reference

6 August 2017

1 reference